PaccMannRL: De novo generation of hit-like anticancer molecules from transcriptomic data via reinforcement learning
Cancer cell lines
DOI:
10.1016/j.isci.2021.102269
Publication Date:
2021-03-07T20:15:03Z
AUTHORS (6)
ABSTRACT
With the advent of deep generative models in computational chemistry, in-silico drug design is undergoing an unprecedented transformation. Although learning approaches have shown potential generating compounds with desired chemical properties, they disregard cellular environment target diseases. Bridging systems biology and design, we present a reinforcement method for de novo molecular from gene expression profiles. We construct hybrid Variational Autoencoder that tailors molecules to target-specific transcriptomic profiles, using anticancer sensitivity prediction model (PaccMann) as reward function. Without incorporating information about drugs, molecule generation biased toward high predicted efficacy against cell lines or cancer types. The can be further refined by subsidiary constraints such toxicity. Our cancer-type-specific candidate drugs are similar drug-likeness, synthesizability, solubility frequently exhibit highest structural similarity known these
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....